Advertisement

Topics

BioMS Medical Corp. Company Profile

00:28 EDT 19th March 2019 | BioPortfolio

BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The technology, MBP8298, is based on over 26 years of research and is a synthetic myelin basic protein peptide comprised of 17 amino acids which is intravenously injected into MS patients as a therapeutic treatment. BioMS Medical is currently conducting a pivotal Phase II/III human clinical trial of MBP8298 in patients with Secondary Progressive MS. Patient enrollment has began in Canada and Europe. The Company’s second technology, HYC750, involves a method for mobilizing hematopoetic cells in humans. BioMS has obtained an exclusive worldwide license to HYC750 from the University of Alberta. HYC750 is based on hyaluronic acid, a naturally occurring and vital component in the connective tissue of humans. Hyaluronic acid is currently used, in various forms, in a large number of commercially available products for applications such as ophthalmologic surgery, rheumatoid arthritis treatment, joint mobilization, wound healing and as a carrier matrix for cells and drugs. In those applications, hyaluronic acid has been shown to be very safe. HYC750 has a number of potential uses, however, the current focus of the Company is on its use as a treatment for the side effects of chemotherapy. BioMS has also entered into an agreement with the University of Alberta, Dr. Leonard I. Wiebe, Dr. James Diakur and BioCyDex Inc. ("BioCyDex"). BioCyDex has exclusive worldwide licenses from the University of Alberta for two technologies. One technology relates to the delivery of anti-viral and chemotherapy drugs into cells for the purpose of improving the effectiveness of those drugs. The other technology relates to the imaging of genes that have been delivered into cells as part of gene therapy treatment. Both technologies are at an early stage of development. BioMS Medical is a publicly traded company on the Toronto Stock Exchange (TSX: MS).

Location

6030-88 Street
Edmonton
Alberta
T6E 6G4
Canada

Contact

Phone: 780-413-7152
Fax: 780-408-3040
Email: info@biomsmedical.com


News Articles [287 Associated News Articles listed on BioPortfolio]

Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV

TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries"), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-d...

Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader

Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;Aleafia patients to access Emblem’s differentiated, high margin de...

Veritas Pharma Signs MOU with Agrima Botanicals Corp. for a Medical Cannabis Research Collaboration

VANCOUVER, British Columbia, Sept. 30, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it ha...

Golden Leaf Holdings’ Subsidiary, Medical Marijuana Group Corp, Acquires Sales License from Health Canada

TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail op...

Correction of Press Release dated September 24, 2018 (‘Golden Leaf Holdings' Subsidiary, Medical Marijuana Group Corp, Acquires Sales License from Health Canada’)

TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF) wishes to advise that the press release issued on September 24,...

CDN MSolar and Blueberries Cannabis Complete Business Combination to Form Blueberries Medical Corp; Shares to Commence Trading February 6, 2019 Under the Symbol “BBM”

TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries") is pleased to announce the completion of its business combination with Blueberri...

Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candi...

Emblem Corp. announces new board appointments

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi ...

PubMed Articles [1848 Associated PubMed Articles listed on BioPortfolio]

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

Learning medical professionalism - the application of appreciative inquiry and social media.

Medical professionalism is often considered difficult to be clearly observed and learned. However, although most medical students or residents affirm the necessity of medical professionalism courses, ...

Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization.

Marijuana use is clinically problematic in depression, and non-medical and medical use may both contribute to barriers to care in this population. Among outpatients with depression, we examined the di...

Insights into medical humanities education in China and the West.

Medical humanity is the soul of health education. Beginning medical students are taught various aspects of basic medicine, such as biochemistry, anatomy, and immunology. However, cultivation of the hu...

Should parents see their teen's medical record? Asking about the effect on adolescent-doctor communication changes attitudes.

Parents routinely access young children's medical records, but medical societies strongly recommend confidential care during adolescence, and most medical centers restrict parental records access duri...

Clinical Trials [1820 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Doctor-Parent Interactions With Medical Scribes

The purpose of the study is to collect outcomes related to a quality improvement project assessing the feasibility and effectiveness of a medical scribe program in which medical scribes ac...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Chart Review Study of Medical Abortion

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal miso...

The Influence of Medical Clowns on the Performance of Pulmonary Function Tests Among Preschooler Children

Medical clowns are known to assist in relaxing children and allowing better cooperation during performance of medical procedures. The ability of medical clowns to improve the motivation o...

Companies [1266 Associated Companies listed on BioPortfolio]

BioMS Medical Corp.

BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The tec...

Hitachi Medical Systems America, Inc.

Hitachi Medical Systems America Inc. (HMSA) markets advanced diagnostic medical imaging systems of Hitachi Medical Corp., Tokyo, Japan. The company has more than 1,500 MRI systems...

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

Precision Engineered Products LLC

More Information about "BioMS Medical Corp." on BioPortfolio

We have published hundreds of BioMS Medical Corp. news stories on BioPortfolio along with dozens of BioMS Medical Corp. Clinical Trials and PubMed Articles about BioMS Medical Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMS Medical Corp. Companies in our database. You can also find out about relevant BioMS Medical Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record